Test group:Large fractionated radiotherapy: individualized selection of small lesions (<3cm) according to the patients recurrence metastasis, physical ability status, etc., single dose 8 Gy, total dos

A Prospective, Multicenter Clinical Study of High- and Low-Dose Radiotherapy in Combination with Adebrelimab and Anlotinib for the Treatment of First-Line Failure/Recurrence of Driver-Negative Non-Small Cell Lung Cancer

High- and low-dose radiotherapy combined with Adebrelimab for advanced solid tumors after failure of first-line therapy